Animal Health Market Overview
Animal diseases with human health implications can adversely impact public health, global trade, and the stability of the agricultural segment of the economy. Healthy animals are more likely to result in safer food supplies, higher farm productivity, reduced environmental impacts, and improved animal well-being. The global Animal Health market is expected to rise at a considerable rate in the forecast period. The market is mainly driven by the large demand for protein food and an increase in the incidence of zoonotic and food-borne diseases globally.
Furthermore, rising disease prevalence has triggered companies to produce advanced vaccines and pharmaceuticals. The high demand has also increased the number of companies undertaking consistent efforts to control pathogen contamination risks and food-borne diseases. This main factor is contributing to the growth of the global Animal Health market.
Additionally, the market is also driven by technological advancements in veterinary healthcare. These advancements include the advent of efficient information management systems, animal owner mobile technology, and vaccine banks. Moreover, the rising number of government initiatives to promote animal health products is also driving the overall development of the market.
Covid-19 Impact on Animal Health Market
In addition, the current Animal Health Market study offers a detailed analysis of the current COVID-19 pandemic impact on the market growth and its influence on the future growth of the Animal Health Market. The recently published report demonstrates the elevation in the demand for the healthcare sector. The healthcare manufacturers have experienced long term as well as short term effect which includes supply shortages, panic buying, and stocking, regulation changes as short-term whereas approval delays and possible trend variations in consumption could be perceived as long-term impacts of COVID-19 on the health and pharmaceutical market.
The increasing need for a cure has pushed vaccine research and manufacturers to the limit. In addition to this, panic conditions have already spurred the demand for many healthcare products and services which are discussed in detail in this report. Moreover, the impact of COVID-19 on overall market revenue for the base year 2020 and its projection up to 2027 is provided in detail in this report.
Animal Health Market Segment Overview
Based on product, the Pharmaceutical segment has the maximum share of the global Animal Health market. It is projected to retain its dominant position throughout the forecast period on account of consistent advancements in veterinary drugs. Pharmaceuticals primarily include anti-inflammatory drugs, parasiticides, antibiotics, and others. In addition to this, it is believed that a significant rise in companion animal ownership has also accelerated the adoption of pharmaceuticals to help increase longevity. As well, the veterinary diagnostics segment is expected to witness lucrative growth in the coming years. Various factors, such as the increasing number of veterinary practitioners & their incomes in developed countries, growing animal health expenditure, and rising incidence of zoonotic diseases, are responsible for the growth of this segment.
Animal Health Market, By Product
· Retail
· E-commerce
· Veterinary Hospitals & Clinics
Animal Health Market, By End-User
· Reference Laboratories
· POC Testing/In-house Testing
· Veterinary Hospitals & Clinics
· Others
Animal Health Regional Overview
Region-wise, North America accounts for a major share in the Animal health market. This is mainly because of the extensive range of definitive measures adopted by government animal welfare organizations that are consistently working for the overall development of animal health. Additionally, technological progressions, rising incidence of zoonotic diseases, and an increasing number of pet owners are anticipated to boost the market growth in this region. Similarly, Asia Pacific will drive substantial growth in the global market. The exponential growth is credited to the increasing awareness relating to pet nutrition and supplies and growing disposable income levels in developing countries of Asia Pacific. Further, steady R&D investments by prominent players in the field of animal health and their efforts to commercialize branded and generic therapeutics at relatively low prices. This factor remarkably propelling the growth of the market in this region.
Animal Health Market, By Geography
· North America (US & Canada)
· Europe (UK, Germany, France, Italy, Spain, Russia & Rest of Europe)
· Asia-Pacific (Japan, China, India, Australia, & South Korea, & Rest of Asia-Pacific)
· LAMEA (Brazil, Saudi Arabia, UAE & Rest of LAMEA)
Animal Health Market Competitor overview
Some key developments and strategies adopted by manufacturers in Animal Health are highlighted below.
· In August 2021, TriRx Pharmaceutical Services, LLC, a leading international CDMO, announced that it has finalized and closed on an agreement with Elanco Animal Health Incorporated to acquire the ownership and operations of its manufacturing site in Shawnee, Kansas. Elanco is a global animal health leader dedicated to innovating and delivering products and services to prevent and treat disease in farm animals and pets. The two companies also entered into a long-term supply agreement for this site.
· In July 2021, Aeronics, Inc., a Pittsburgh-based startup that develops innovative oxygen technologies for veterinary use, announced a collaboration with MWI Animal Health, a leading distributor of animal health products, to expedite veterinarians' access to portable oxygen. This system can be used in veterinary practice, during transport, and by pet owners at home.
Animal Health Market, Key Players
· Zoetis
· Ceva Santé Animale
· Merck Animal Health
· Vetiquinol S.A.
· Boehringer Ingelheim GmbH
· Bayer AG
· Virbac
· Heska
· Nutreco N.V.
Animal diseases with human health implications can adversely impact public health, global trade, and the stability of the agricultural segment of the economy. Healthy animals are more likely to result in safer food supplies, higher farm productivity, reduced environmental impacts, and improved animal well-being. The global Animal Health market is expected to rise at a considerable rate in the forecast period. The market is mainly driven by the large demand for protein food and an increase in the incidence of zoonotic and food-borne diseases globally.
Furthermore, rising disease prevalence has triggered companies to produce advanced vaccines and pharmaceuticals. The high demand has also increased the number of companies undertaking consistent efforts to control pathogen contamination risks and food-borne diseases. This main factor is contributing to the growth of the global Animal Health market.
Additionally, the market is also driven by technological advancements in veterinary healthcare. These advancements include the advent of efficient information management systems, animal owner mobile technology, and vaccine banks. Moreover, the rising number of government initiatives to promote animal health products is also driving the overall development of the market.
Covid-19 Impact on Animal Health Market
In addition, the current Animal Health Market study offers a detailed analysis of the current COVID-19 pandemic impact on the market growth and its influence on the future growth of the Animal Health Market. The recently published report demonstrates the elevation in the demand for the healthcare sector. The healthcare manufacturers have experienced long term as well as short term effect which includes supply shortages, panic buying, and stocking, regulation changes as short-term whereas approval delays and possible trend variations in consumption could be perceived as long-term impacts of COVID-19 on the health and pharmaceutical market.
The increasing need for a cure has pushed vaccine research and manufacturers to the limit. In addition to this, panic conditions have already spurred the demand for many healthcare products and services which are discussed in detail in this report. Moreover, the impact of COVID-19 on overall market revenue for the base year 2020 and its projection up to 2027 is provided in detail in this report.
Animal Health Market Segment Overview
Based on product, the Pharmaceutical segment has the maximum share of the global Animal Health market. It is projected to retain its dominant position throughout the forecast period on account of consistent advancements in veterinary drugs. Pharmaceuticals primarily include anti-inflammatory drugs, parasiticides, antibiotics, and others. In addition to this, it is believed that a significant rise in companion animal ownership has also accelerated the adoption of pharmaceuticals to help increase longevity. As well, the veterinary diagnostics segment is expected to witness lucrative growth in the coming years. Various factors, such as the increasing number of veterinary practitioners & their incomes in developed countries, growing animal health expenditure, and rising incidence of zoonotic diseases, are responsible for the growth of this segment.
Animal Health Market, By Product
- Vaccines
- Live Attenuated Vaccines
- DNA Vaccines
- Recombinant Vaccines
- Inactivated Vaccines
- Others
- Pharmaceuticals
- Parasiticides
- Anti-infectives
- Anti-inflammatory
- Analgesics
- Others
- Feed Additives
- Nutritional
- Medicinal
- Diagnostics
- Instruments
- Consumables
- Medical Devices & Disposables
- Critical Care
- Anesthesia Equipment
- Fluid Management Equipment
- Temperature Management Equipment
- Rescue & Resuscitation Equipment
- Research Equipment
- Patient Monitoring Equipment
- Others
- Veterinary Telehealth
- Veterinary Software
- Livestock Monitoring
· Retail
· E-commerce
· Veterinary Hospitals & Clinics
Animal Health Market, By End-User
· Reference Laboratories
· POC Testing/In-house Testing
· Veterinary Hospitals & Clinics
· Others
Animal Health Regional Overview
Region-wise, North America accounts for a major share in the Animal health market. This is mainly because of the extensive range of definitive measures adopted by government animal welfare organizations that are consistently working for the overall development of animal health. Additionally, technological progressions, rising incidence of zoonotic diseases, and an increasing number of pet owners are anticipated to boost the market growth in this region. Similarly, Asia Pacific will drive substantial growth in the global market. The exponential growth is credited to the increasing awareness relating to pet nutrition and supplies and growing disposable income levels in developing countries of Asia Pacific. Further, steady R&D investments by prominent players in the field of animal health and their efforts to commercialize branded and generic therapeutics at relatively low prices. This factor remarkably propelling the growth of the market in this region.
Animal Health Market, By Geography
· North America (US & Canada)
· Europe (UK, Germany, France, Italy, Spain, Russia & Rest of Europe)
· Asia-Pacific (Japan, China, India, Australia, & South Korea, & Rest of Asia-Pacific)
· LAMEA (Brazil, Saudi Arabia, UAE & Rest of LAMEA)
Animal Health Market Competitor overview
Some key developments and strategies adopted by manufacturers in Animal Health are highlighted below.
· In August 2021, TriRx Pharmaceutical Services, LLC, a leading international CDMO, announced that it has finalized and closed on an agreement with Elanco Animal Health Incorporated to acquire the ownership and operations of its manufacturing site in Shawnee, Kansas. Elanco is a global animal health leader dedicated to innovating and delivering products and services to prevent and treat disease in farm animals and pets. The two companies also entered into a long-term supply agreement for this site.
· In July 2021, Aeronics, Inc., a Pittsburgh-based startup that develops innovative oxygen technologies for veterinary use, announced a collaboration with MWI Animal Health, a leading distributor of animal health products, to expedite veterinarians' access to portable oxygen. This system can be used in veterinary practice, during transport, and by pet owners at home.
Animal Health Market, Key Players
· Zoetis
· Ceva Santé Animale
· Merck Animal Health
· Vetiquinol S.A.
· Boehringer Ingelheim GmbH
· Bayer AG
· Virbac
· Heska
· Nutreco N.V.
1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
4. Key Insights
- 4.1. Key Emerging Trends – For Major Countries
- 4.2. Latest Technological Advancement
- 4.3. Regulatory Landscape
- 4.4. Industry SWOT Analysis
- 4.5. Porters Five Forces Analysis
5. Global Animal Health Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 5.1. Key Findings / Summary
- 5.2. Market Analysis, Insights and Forecast – By Product
- 5.2.1. Vaccines
- 5.2.1.1. Live Attenuated Vaccines
- 5.2.1.2. DNA Vaccines
- 5.2.1.3. Recombinant Vaccines
- 5.2.1.4. Inactivated Vaccines
- 5.2.1.5. Others
- 5.2.2. Pharmaceuticals
- 5.2.2.1. Parasiticides
- 5.2.2.2. Anti-infectives
- 5.2.2.3. Anti-inflammatory
- 5.2.2.4. Analgesics
- 5.2.2.5. Others
- 5.2.3. Feed Additives
- 5.2.3.1. Nutritional
- 5.2.3.2. Medicinal
- 5.2.4. Diagnostics
- 5.2.4.1. Instruments
- 5.2.4.2. Consumables
- 5.2.5. Medical Devices & Disposables
- 5.2.5.1. Critical Care
- 5.2.5.2. Anesthesia Equipment
- 5.2.5.3. Fluid Management Equipment
- 5.2.5.4. Temperature Management Equipment
- 5.2.5.5. Rescue & Resuscitation Equipment
- 5.2.5.6. Research Equipment
- 5.2.5.7. Patient Monitoring Equipment
- 5.2.6. Others
- 5.2.6.1. Veterinary Telehealth
- 5.2.6.2. Veterinary Software
- 5.2.6.3. Livestock Monitoring
- 5.2.1. Vaccines
- 5.3.1. Retail
- 5.3.2. E-commerce
- 5.3.3. Veterinary Hospitals & Clinics
- 5.4.1. Reference Laboratories
- 5.4.2. POC Testing/In-house Testing
- 5.4.3. Veterinary Hospitals & Clinics
- 5.4.4. Others
- 5.5.1. North America
- 5.5.2. Europe
- 5.5.3. Asia Pacific
- 5.5.4. Latin America, Middle East and Africa
6. North America Animal Health Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 6.1. Key Findings / Summary
- 6.2. Market Analysis, Insights and Forecast – By Product
- 6.2.1. Vaccines
- 6.2.1.1. Live Attenuated Vaccines
- 6.2.1.2. DNA Vaccines
- 6.2.1.3. Recombinant Vaccines
- 6.2.1.4. Inactivated Vaccines
- 6.2.1.5. Others
- 6.2.2. Pharmaceuticals
- 6.2.2.1. Parasiticides
- 6.2.2.2. Anti-infectives
- 6.2.2.3. Anti-inflammatory
- 6.2.2.4. Analgesics
- 6.2.2.5. Others
- 6.2.3. Feed Additives
- 6.2.3.1. Nutritional
- 6.2.3.2. Medicinal
- 6.2.4. Diagnostics
- 6.2.4.1. Instruments
- 6.2.4.2. Consumables
- 6.2.5. Medical Devices & Disposables
- 6.2.5.1. Critical Care
- 6.2.5.2. Anesthesia Equipment
- 6.2.5.3. Fluid Management Equipment
- 6.2.5.4. Temperature Management Equipment
- 6.2.5.5. Rescue & Resuscitation Equipment
- 6.2.5.6. Research Equipment
- 6.2.5.7. Patient Monitoring Equipment
- 6.2.6. Others
- 6.2.6.1. Veterinary Telehealth
- 6.2.6.2. Veterinary Software
- 6.2.6.3. Livestock Monitoring
- 6.2.1. Vaccines
- 6.3.1. Retail
- 6.3.2. E-commerce
- 6.3.3. Veterinary Hospitals & Clinics
- 6.4.1. Reference Laboratories
- 6.4.2. POC Testing/In-house Testing
- 6.4.3. Veterinary Hospitals & Clinics
- 6.4.4. Others
- 6.5.1. U.S.
- 6.5.2. Canada
7. Europe Animal Health Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 7.1. Key Findings / Summary
- 7.2. Market Analysis, Insights and Forecast – By Product
- 7.2.1. Vaccines
- 7.2.1.1. Live Attenuated Vaccines
- 7.2.1.2. DNA Vaccines
- 7.2.1.3. Recombinant Vaccines
- 7.2.1.4. Inactivated Vaccines
- 7.2.1.5. Others
- 7.2.2. Pharmaceuticals
- 7.2.2.1. Parasiticides
- 7.2.2.2. Anti-infectives
- 7.2.2.3. Anti-inflammatory
- 7.2.2.4. Analgesics
- 7.2.2.5. Others
- 7.2.3. Feed Additives
- 7.2.3.1. Nutritional
- 7.2.3.2. Medicinal
- 7.2.4. Diagnostics
- 7.2.4.1. Instruments
- 7.2.4.2. Consumables
- 7.2.5. Medical Devices & Disposables
- 7.2.5.1. Critical Care
- 7.2.5.2. Anesthesia Equipment
- 7.2.5.3. Fluid Management Equipment
- 7.2.5.4. Temperature Management Equipment
- 7.2.5.5. Rescue & Resuscitation Equipment
- 7.2.5.6. Research Equipment
- 7.2.5.7. Patient Monitoring Equipment
- 7.2.6. Others
- 7.2.6.1. Veterinary Telehealth
- 7.2.6.2. Veterinary Software
- 7.2.6.3. Livestock Monitoring
- 7.2.1. Vaccines
- 7.3.1. Retail
- 7.3.2. E-commerce
- 7.3.3. Veterinary Hospitals & Clinics
- 7.4.1. Reference Laboratories
- 7.4.2. POC Testing/In-house Testing
- 7.4.3. Veterinary Hospitals & Clinics
- 7.4.4. Others
- 7.5.1. UK
- 7.5.2. Germany
- 7.5.3. France
- 7.5.4. Italy
- 7.5.5. Spain
- 7.5.6. Russia
- 7.5.7. Rest of Europe
8. Asia Pacific Animal Health Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 8.1. Key Findings / Summary
- 8.2. Market Analysis, Insights and Forecast – By Product
- 8.2.1. Vaccines
- 8.2.1.1. Live Attenuated Vaccines
- 8.2.1.2. DNA Vaccines
- 8.2.1.3. Recombinant Vaccines
- 8.2.1.4. Inactivated Vaccines
- 8.2.1.5. Others
- 8.2.2. Pharmaceuticals
- 8.2.2.1. Parasiticides
- 8.2.2.2. Anti-infectives
- 8.2.2.3. Anti-inflammatory
- 8.2.2.4. Analgesics
- 8.2.2.5. Others
- 8.2.3. Feed Additives
- 8.2.3.1. Nutritional
- 8.2.3.2. Medicinal
- 8.2.4. Diagnostics
- 8.2.4.1. Instruments
- 8.2.4.2. Consumables
- 8.2.5. Medical Devices & Disposables
- 8.2.5.1. Critical Care
- 8.2.5.2. Anesthesia Equipment
- 8.2.5.3. Fluid Management Equipment
- 8.2.5.4. Temperature Management Equipment
- 8.2.5.5. Rescue & Resuscitation Equipment
- 8.2.5.6. Research Equipment
- 8.2.5.7. Patient Monitoring Equipment
- 8.2.6. Others
- 8.2.6.1. Veterinary Telehealth
- 8.2.6.2. Veterinary Software
- 8.2.6.3. Livestock Monitoring
- 8.2.1. Vaccines
- 8.3.1. Retail
- 8.3.2. E-commerce
- 8.3.3. Veterinary Hospitals & Clinics
- 8.4.1. Reference Laboratories
- 8.4.2. POC Testing/In-house Testing
- 8.4.3. Veterinary Hospitals & Clinics
- 8.4.4. Others
- 8.5.1. China
- 8.5.2. India
- 8.5.3. Japan
- 8.5.4. Australia
- 8.5.5. South East Asia
- 8.5.6. Rest of Asia Pacific
9. Latin America, Middle East and Africa Animal Health Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 9.1. Key Findings / Summary
- 9.2. Market Analysis, Insights and Forecast – By Product
- 9.2.1. Vaccines
- 9.2.1.1. Live Attenuated Vaccines
- 9.2.1.2. DNA Vaccines
- 9.2.1.3. Recombinant Vaccines
- 9.2.1.4. Inactivated Vaccines
- 9.2.1.5. Others
- 9.2.2. Pharmaceuticals
- 9.2.2.1. Parasiticides
- 9.2.2.2. Anti-infectives
- 9.2.2.3. Anti-inflammatory
- 9.2.2.4. Analgesics
- 9.2.2.5. Others
- 9.2.3. Feed Additives
- 9.2.3.1. Nutritional
- 9.2.3.2. Medicinal
- 9.2.4. Diagnostics
- 9.2.4.1. Instruments
- 9.2.4.2. Consumables
- 9.2.5. Medical Devices & Disposables
- 9.2.5.1. Critical Care
- 9.2.5.2. Anesthesia Equipment
- 9.2.5.3. Fluid Management Equipment
- 9.2.5.4. Temperature Management Equipment
- 9.2.5.5. Rescue & Resuscitation Equipment
- 9.2.5.6. Research Equipment
- 9.2.5.7. Patient Monitoring Equipment
- 9.2.6. Others
- 9.2.6.1. Veterinary Telehealth
- 9.2.6.2. Veterinary Software
- 9.2.6.3. Livestock Monitoring
- 9.2.1. Vaccines
- 9.3.1. Retail
- 9.3.2. E-commerce
- 9.3.3. Veterinary Hospitals & Clinics
- 9.4.1. Reference Laboratories
- 9.4.2. POC Testing/In-house Testing
- 9.4.3. Veterinary Hospitals & Clinics
- 9.4.4. Others
- 9.5.1. Brazil
- 9.5.2. Saudi Arabia
- 9.5.3. UAE
- 9.5.4. Rest of LAMEA
10. Competitive Analysis
- 10.1. Company Market Share Analysis, 2018
- 10.2. Key Industry Developments
- 10.3. Company Profile
- 10.4. Zoetis
- 10.4.1. Business Overview
- 10.4.2. Segment 1 & Service Offering
- 10.4.3. Overall Revenue
- 10.4.4. Geographic Presence
- 10.4.5. Recent Development
- 10.5. Ceva Santé Animale
- 10.6. Merck Animal Health
- 10.7. Vetiquinol S.A.
- 10.8. Boehringer Ingelheim GmbH
- 10.9. Bayer AG
- 10.10. Virbac
- 10.11. Heska
Research Process
Data Library Research are conducted by industry experts who offer insight on industry structure, market segmentations technology assessment and competitive landscape (CL), and penetration, as well as on emerging trends. Their analysis is based on primary interviews (~ 80%) and secondary research (~ 20%) as well as years of professional expertise in their respective industries. Adding to this, by analysing historical trends and current market positions, our analysts predict where the market will be headed for the next five years. Furthermore, the varying trends of segment & categories geographically presented are also studied and the estimated based on the primary & secondary research.
In this particular report from the supply side Data Library Research has conducted primary surveys (interviews) with the key level executives (VP, CEO’s, Marketing Director, Business Development Manager and SOFT) of the companies that active & prominent as well as the midsized organization
FIGURE 1: DLR RESEARH PROCESS
Extensive primary research was conducted to gain a deeper insight of the market and industry performance. The analysis is based on both primary and secondary research as well as years of professional expertise in the respective industries.
In addition to analysing current and historical trends, our analysts predict where the market is headed over the next five years.
It varies by segment for these categories geographically presented in the list of market tables. Speaking about this particular report we have conducted primary surveys (interviews) with the key level executives (VP, CEO’s, Marketing Director, Business Development Manager and many more) of the major players active in the market.
Secondary ResearchSecondary research was mainly used to collect and identify information useful for the extensive, technical, market-oriented, and Friend’s study of the Global Extra Neutral Alcohol. It was also used to obtain key information about major players, market classification and segmentation according to the industry trends, geographical markets, and developments related to the market and technology perspectives. For this study, analysts have gathered information from various credible sources, such as annual reports, sec filings, journals, white papers, SOFT presentations, and company web sites.
Market Size EstimationBoth, top-down and bottom-up approaches were used to estimate and validate the size of the Global market and to estimate the size of various other dependent submarkets in the overall Extra Neutral Alcohol. The key players in the market were identified through secondary research and their market contributions in the respective geographies were determined through primary and secondary research.
Forecast Model
